Minerva Neurosciences (NERV) Return on Capital Employed Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 68,255.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 2,665.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 31,429.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2,503.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -105.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,400.00
10 Minerva Neurosciences 215.11 Mn 215.11 Mn - 2,729.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,729.00
Dec 31, 2025 3,396.00
Sep 30, 2025 606.00
Jun 30, 2025 371.00
Mar 31, 2025 -968.00
Dec 31, 2024 -1,803.00
Sep 30, 2024 -2,712.00
Jun 30, 2024 -2,424.00
Mar 31, 2024 -363.00
Dec 31, 2023 423.00
Sep 30, 2023 3,503.00
Jun 30, 2023 3,305.00
Mar 31, 2023 2,048.00
Dec 31, 2022 865.00
Sep 30, 2022 -3,724.00
Jun 30, 2022 -3,752.00
Mar 31, 2022 -7,304.00
Dec 31, 2021 -5,684.00
Sep 30, 2021 670.00
Jun 30, 2021 1,837.00
Mar 31, 2021 11,691.00
Dec 31, 2020 8,985.00
Sep 30, 2020 1,556.00
Jun 30, 2020 -191.00
Mar 31, 2020 -6,544.00
Dec 31, 2019 -5,005.00
Sep 30, 2019 -2,270.00
Jun 30, 2019 -1,840.00
Mar 31, 2019 -1,798.00
Dec 31, 2018 -1,398.00
Sep 30, 2018 -443.00
Jun 30, 2018 364.00
Mar 31, 2018 180.00
Dec 31, 2017 100.00
Sep 30, 2017 -519.00
Jun 30, 2017 -898.00
Mar 31, 2017 715.00
Dec 31, 2016 873.00
Sep 30, 2016 687.00
Jun 30, 2016 2,635.00
Mar 31, 2016 3,768.00
Dec 31, 2015 4,905.00
Sep 30, 2015 5,387.00